Selective Targeting of Cancer-Related G-Quadruplex Structures by the Natural Compound Dicentrine.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Feb 2023
Historique:
received: 21 01 2023
revised: 14 02 2023
accepted: 15 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

Aiming to identify highly effective and selective G-quadruplex ligands as anticancer candidates, five natural compounds were investigated here, i.e., the alkaloids Canadine, D-Glaucine and Dicentrine, as well as the flavonoids Deguelin and Millettone, selected as analogs of compounds previously identified as promising G-quadruplex-targeting ligands. A preliminary screening with the G-quadruplex on the Controlled Pore Glass assay proved that, among the investigated compounds, Dicentrine is the most effective ligand of telomeric and oncogenic G-quadruplexes, also showing good G-quadruplex vs. duplex selectivity. In-depth studies in solution demonstrated the ability of Dicentrine to thermally stabilize telomeric and oncogenic G-quadruplexes without affecting the control duplex. Interestingly, it showed higher affinity for the investigated G-quadruplex structures over the control duplex (K

Identifiants

pubmed: 36835480
pii: ijms24044070
doi: 10.3390/ijms24044070
pmc: PMC9959918
pii:
doi:

Substances chimiques

dicentrine J2ZGT5M0N7
Ligands 0
Antineoplastic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Italian Association for Cancer Research
ID : AIRC IG2020 n. 25046 to D. Mo.

Références

J Med Chem. 2009 May 14;52(9):2863-74
pubmed: 19385599
Nucleic Acids Res. 1996 Mar 1;24(5):829-34
pubmed: 8600448
Pharmaceutics. 2021 Oct 03;13(10):
pubmed: 34683905
J Chem Theory Comput. 2015 Dec 8;11(12):5723-36
pubmed: 26588601
J Biol Chem. 2002 Nov 15;277(46):43763-70
pubmed: 12226097
Cell Death Dis. 2018 Sep 24;9(10):996
pubmed: 30250025
ChemistryOpen. 2022 May;11(5):e202200090
pubmed: 35608081
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1341-1352
pubmed: 28130159
Biochem Pharmacol. 1999 May 15;57(10):1141-5
pubmed: 11230801
Anal Chim Acta. 2018 Nov 7;1030:133-141
pubmed: 30032762
Nat Commun. 2019 Mar 1;10(1):1001
pubmed: 30824709
Nucleic Acids Res. 2006 May 19;34(9):2723-35
pubmed: 16714449
Nucleic Acids Res. 2007;35(15):4927-40
pubmed: 17626043
J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
Proc Natl Acad Sci U S A. 1981 Apr;78(4):2179-83
pubmed: 6941276
Pharmaceutics. 2022 Nov 01;14(11):
pubmed: 36365179
Histol Histopathol. 2003 Apr;18(2):541-50
pubmed: 12647805
Int J Cancer. 2011 Dec 15;129(12):2916-27
pubmed: 21472727
Top Curr Chem. 2013;330:211-42
pubmed: 22851158
Biochemistry. 2005 Feb 15;44(6):2048-58
pubmed: 15697230
Planta Med. 2001 Aug;67(6):561-4
pubmed: 11509983
J Chem Theory Comput. 2016 Aug 9;12(8):4114-27
pubmed: 27300587
Int J Mol Sci. 2019 Oct 04;20(19):
pubmed: 31590335
Biochem Biophys Res Commun. 2020 Oct 8;531(1):45-50
pubmed: 32312519
Bioorg Med Chem. 2008 Apr 1;16(7):3641-51
pubmed: 18295494
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
J Ethnopharmacol. 2019 May 23;236:250-257
pubmed: 30849504
Anal Chem. 2014 May 6;86(9):4126-30
pubmed: 24725064
Molecules. 2019 Apr 05;24(7):
pubmed: 30959739
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
Planta Med. 2004 Jun;70(6):585-8
pubmed: 15229812
Nat Chem. 2013 Mar;5(3):182-6
pubmed: 23422559
In Vivo. 2008 May-Jun;22(3):305-9
pubmed: 18610740
Nat Rev Mol Cell Biol. 2020 Aug;21(8):459-474
pubmed: 32313204
Org Biomol Chem. 2021 Nov 25;19(45):9953-9965
pubmed: 34747958
J Chem Theory Comput. 2012 Sep 11;8(9):3314-21
pubmed: 26605738
Top Curr Chem. 2013;330:23-46
pubmed: 22790417
Planta Med. 1998 Apr;64(3):212-5
pubmed: 9581516
Biochem Pharmacol. 2010 Apr 15;79(8):1092-9
pubmed: 20005213
Eur J Med Chem. 2019 Feb 1;163:295-306
pubmed: 30529547
Br J Pharmacol. 1999 Aug;127(7):1641-51
pubmed: 10455321
Int J Cancer. 2008 Jan 1;122(1):5-14
pubmed: 17764071
Genes (Basel). 2019 Jan 29;10(2):
pubmed: 30700033
Chemistry. 2021 Jun 16;27(34):8832-8845
pubmed: 33890349
J Ethnopharmacol. 2007 Aug 15;113(1):179-82
pubmed: 17574358
Mol Cell Biochem. 2015 May;403(1-2):85-94
pubmed: 25670016
J Am Chem Soc. 2011 Nov 9;133(44):17673-80
pubmed: 21967482
Mol Cancer. 2021 Feb 25;20(1):40
pubmed: 33632214

Auteurs

Chiara Platella (C)

Department of Chemical Sciences, University of Naples Federico II, Complesso Universitario di Monte S. Angelo, Via Cintia, 21, 80126 Napoli, Italy.

Francesca Ghirga (F)

Department of Chemistry and Technology of Drugs, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.

Domenica Musumeci (D)

Department of Chemical Sciences, University of Naples Federico II, Complesso Universitario di Monte S. Angelo, Via Cintia, 21, 80126 Napoli, Italy.

Deborah Quaglio (D)

Department of Chemistry and Technology of Drugs, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.

Pasquale Zizza (P)

Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy.

Sara Iachettini (S)

Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy.

Carmen D'Angelo (C)

Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy.

Annamaria Biroccio (A)

Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy.

Bruno Botta (B)

Department of Chemistry and Technology of Drugs, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.

Mattia Mori (M)

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.

Daniela Montesarchio (D)

Department of Chemical Sciences, University of Naples Federico II, Complesso Universitario di Monte S. Angelo, Via Cintia, 21, 80126 Napoli, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH